Oscar Quintana-Bustamante (O Quintana-Bustamante)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Polycystic Kidney Disease

Tyrosine Kinase

Top Venues

Nature communications

Clinical genetics

This page only lists publications with an associated author ORCID identifier.

Publications

Clara Bueno, Raul Torres-Ruíz, Talía Velasco-Hernandez, William C Earnshaw, Paolo Petazzi, Alba Martinez-Moreno, Virginia Carolina Rodríguez-Cortez, Meritxell Vinyoles, Sandra Cantilena, Owen Williams, Nerea Vega-García, Sandra Rodríguez-Perales, José Carlos Segovia, Oscar Quintana-Bustamante, Anindita Roy, Claus Meyer, Rolf Marschalek, Alastair L Smith, Thomas A Milne, Mario F Fraga, Juan Ramón Ramón Tejedor, Pablo Menendez
A human genome editing-based MLL::AF4 B-cell ALL model recapitulates key cellular and molecular leukemogenic features. Blood (2023)
Marta Martinez-Lage, Raul Torres-Ruíz, Pilar Puig-Serra, P Moreno-Gaona, M C Martin, F J Moya, Oscar Quintana-Bustamante, Susana Garcia-Silva, Angel Montero Carcaboso, P Petazzi, C Bueno, Jaume Catala-Mora, Hector Peinado, José Carlos Segovia, P Menendez, Sandra Rodríguez-Perales
In vivo CRISPR/Cas9 targeting of fusion oncogenes for selective elimination of cancer cells. Nature communications 11 (1) (2020)
Juan A Bueren, Oscar Quintana-Bustamante, Elena Almarza, Susana Navarro, Paula Río, José C Segovia, Guillermo Guenechea
Advances in the gene therapy of monogenic blood cell diseases. Clinical genetics 97 (1) (2019)
Oscar Quintana-Bustamante, Sara Fañanas-Baquero, Israel Orman, Raul Torres, Philippe Duchateau, Laurent Poirot, Agnès Gouble, Juan A Bueren, Jose C Segovia
Gene editing of PKLR gene in human hematopoietic progenitors through 5' and 3' UTR modified TALEN mRNA. PloS one 14 (10) (2019)